Vaccines · Rare Disease Therapeutics
Sanofi revenue, results and funding
Sanofi filed revenue of €41.1B for 2024.
Data updated Nov 15, 2026 · Back to the company report
€41.1BRevenue, 2024
€7.8BNet income, 2025
106,566Employees, 2017
SANEuronext Paris
Results by year
| Year | Revenue | Net income | Total assets | Employees |
|---|---|---|---|---|
| 2025 | – | €7.8B | €126.8B | – |
| 2024 | €41.1B | €5.6B | €132.8B | – |
| 2023 | €43.1B | €5.4B | €126.5B | – |
| 2022 | €43B | €8.4B | €126.7B | – |
| 2021 | €37.8B | €6.2B | €120.2B | – |
| 2020 | €36B | €12.3B | €114.4B | – |
| 2019 | €36.1B | €2.8B | €112.6B | – |
| 2018 | €34.5B | €4.3B | €111.4B | – |
| 2017 | €35.1B | €8.4B | €99.8B | 106,566 |
| 2016 | €33.8B | €4.7B | €104.7B | – |
| 2015 | €34.1B | €4.3B | €102.3B | – |
| 2014 | €31.4B | €4.4B | €97.4B | – |
| 2013 | €30.7B | €3.7B | €96.1B | – |
| 2012 | €34.9B | €5B | – | – |
| 2011 | €33.4B | €5.7B | – | – |
Sources: Wikidata, SEC
Rounds and grants
| Year | Round | Amount |
|---|---|---|
| 2025 | Grant | $281k |
| 2024 | Grant | $281k |
| 2023 | Grant | $563k |
| 2023 | Grant | $281k |
| 2016 | Grant | $269k |
| 2016 | Grant | $87k |
| 2015 | Grant | $269k |
Sources: funding announcements, SEC filings, grant registers
How to cite
Sanofi, Financials. Alion, Nov 15, 2026. https://alion.io/company/sanofi/financials